First-in-Human Study of SRT-015 in Healthy Subjects.
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This is phase 1 first-in-human trial evaluating SRT-015 to assess safety, tolerability and
pharmacokinetics. This study will be conducted in 3 parts - SAD, MAD and Food Effect with
target of 96 healthy volunteers.
This will be a single center, Phase 1, randomized, double-blind, placebo controlled, SAD and
MAD study of dose escalation cohorts evaluating administration of SRT-015 or placebo.
Additionally, PK will be assessed in fed and fasting states.